You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Details for Patent: 10,912,754


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,912,754 protect, and when does it expire?

Patent 10,912,754 protects SUNOSI and is included in one NDA.

This patent has eleven patent family members in ten countries.

Summary for Patent: 10,912,754
Title:Methods and compositions for treating excessive sleepiness
Abstract: The present invention relates to carbamoyl phenylalaninol compounds and methods of using the same to treat disorders. The invention further relates to the development of methods for treating excessive sleepiness in a subject, e.g., due to narcolepsy or obstructive sleep apnea, with the surprising outcome that "normal" levels of wakefulness are achieved based on standard objective and subjective sleepiness tests.
Inventor(s): Carter; Lawrence Patrick (Palo Alto, CA), Lu; Yuan (N/A), Zomorodi; Katayoun (San Jose, CA)
Assignee: Jazz Pharmaceuticals Ireland Limited (Dublin, IE)
Application Number:16/877,717
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,912,754

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This analysis will delve into the specifics of United States Patent 10,912,754, exploring its claims, the patent landscape it operates within, and the implications for stakeholders.

Patent Overview

United States Patent 10,912,754 is part of a broader portfolio of patents, often involved in litigation and challenges related to patent validity and infringement. Here, we will focus on the key aspects of this patent.

Claims Analysis

Claim Structure

Patent claims are the heart of any patent, defining the scope of the invention and what is protected. The claims of U.S. Patent 10,912,754 would typically be categorized into independent and dependent claims. Independent claims stand alone and define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations to the independent claims[3].

Claim Scope

To understand the scope, one must analyze the language and specificity of each claim. For example, if the patent pertains to a pharmaceutical or medical device, the claims might detail specific compounds, formulations, or device components. The scope would also be influenced by any prior art and the differentiation from existing patents.

Patent Landscape

Related Patents

U.S. Patent 10,912,754 is likely part of a family of patents, as seen in other cases where multiple patents are interconnected through continuations-in-part or continuations. This is evident from the litigation documents where multiple patents are challenged simultaneously, indicating a complex web of related inventions[2].

Litigation Context

The patent is mentioned in litigation documents, such as those involving Hetero and Axsome, where Hetero challenges the validity and enforceability of several patents, including U.S. Patent 10,912,754. This indicates that the patent is part of an ongoing legal battle over intellectual property rights[2].

Obviousness-Type Double Patenting (ODP)

ODP Analysis

In cases involving multiple related patents, the issue of obviousness-type double patenting (ODP) often arises. ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of Patent Term Adjustment (PTA)[1].

Implications for U.S. Patent 10,912,754

If U.S. Patent 10,912,754 is part of a family where ODP is a concern, the validity of its claims could be challenged based on earlier-expiring patents within the same family. This was seen in the case of Cellect LLC, where multiple patents were invalidated due to ODP issues[1].

Patent Term Adjustment (PTA)

PTA and Patent Term

PTA can extend the term of a patent to compensate for delays during the prosecution process. However, as seen in the Cellect LLC case, PTA does not extend the term past the date of a terminal disclaimer, which can impact the overall patent term and validity[1].

Quality and Examination

USPTO Guidelines

The quality of patent examination is a critical factor in determining the validity and scope of patent claims. The USPTO has been recommended to more consistently define patent quality and articulate this definition in agency documents and guidance. This ensures that examiners have sufficient time and resources to perform thorough examinations, which can affect the robustness of patents like U.S. Patent 10,912,754[4].

Economic and Strategic Implications

Market Impact

The validity and scope of U.S. Patent 10,912,754 can significantly impact the market, particularly if it is involved in high-stakes litigation. Companies like Axsome and Hetero have substantial interests in the outcome, as it affects their ability to market products and protect their intellectual property[2].

Competitive Landscape

In a competitive landscape, the strength and validity of patents can be a decisive factor. Companies must carefully navigate the patent landscape to avoid infringement and ensure their own patents are robust enough to withstand challenges.

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of the patent.
  • Patent Landscape: The patent is part of a larger family and is subject to challenges and litigation.
  • ODP and PTA: Issues related to obviousness-type double patenting and patent term adjustment can significantly impact the validity of the patent.
  • Market Impact: The outcome of litigation involving this patent can have substantial economic and strategic implications.

FAQs

  1. What is the significance of ODP in patent law? ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of PTA.

  2. How does PTA affect the term of a patent? PTA can extend the term of a patent to compensate for delays during the prosecution process, but it does not extend the term past the date of a terminal disclaimer.

  3. What is the role of the USPTO in ensuring patent quality? The USPTO is recommended to consistently define patent quality and provide clear guidance to ensure examiners have sufficient time and resources for thorough examinations.

  4. Why is the scope of patent claims important? The scope of patent claims defines what is protected and what is not, which is crucial for avoiding infringement and defending against challenges.

  5. How does litigation impact the validity of a patent? Litigation can challenge the validity and enforceability of a patent, potentially leading to the invalidation of claims or the entire patent if it is found to be unpatentable or infringed upon.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,912,754

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Axsome Malta SUNOSI solriamfetol hydrochloride TABLET;ORAL 211230-001 Jun 17, 2019 RX Yes No 10,912,754 ⤷  Subscribe TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS ASSOCIATED WITH OBSTRUCTIVE SLEEP APNEA (OSA) IN AN ADULT THROUGH A DOSING REGIMEN THAT INCLUDES ORAL ADMINISTRATION OF 75 MG ONCE DAILY FOR AT LEAST 3 DAYS FOLLOWED BY 150 MG ONCE DAILY ⤷  Subscribe
Axsome Malta SUNOSI solriamfetol hydrochloride TABLET;ORAL 211230-002 Jun 17, 2019 RX Yes Yes 10,912,754 ⤷  Subscribe TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS ASSOCIATED WITH OBSTRUCTIVE SLEEP APNEA (OSA) IN AN ADULT THROUGH A DOSING REGIMEN THAT INCLUDES ORAL ADMINISTRATION OF 75 MG ONCE DAILY FOR AT LEAST 3 DAYS FOLLOWED BY 150 MG ONCE DAILY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.